Kiniksa Pharmaceuticals International stockKNSA
Kiniksa Pharmaceuticals International trades at $88.34, 10.3% below its 52-week high (Oct 30, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +114.2% year to date, +125.7% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Mar 2, 2027.
Ratings, candles, signals and the screener for KNSA — after you log in
Open the terminalFrequently asked questions about Kiniksa Pharmaceuticals International
What is the Kiniksa Pharmaceuticals International stock price?
At the close on Nov 5, 2026: $88.34 (−8.09% on the day). 52-week high: $98.48 on Oct 30, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Kiniksa Pharmaceuticals International report earnings?
The next quarterly report is on Mar 2, 2027. Last quarter, earnings per share changed +143% year over year, revenue +58%.
Does Kiniksa Pharmaceuticals International pay dividends?
No, Kiniksa Pharmaceuticals International does not pay dividends.
Where does Kiniksa Pharmaceuticals International trade and how to buy it?
Ticker KNSA, exchange Nasdaq, listed since 2018. You can buy it through a broker with access to US exchanges.
Should I buy Kiniksa Pharmaceuticals International now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for KNSA are in the terminal after you log in.